Authors:
SEGARRA V
CRESPO MI
PUJOL F
BELETA J
DOMENECH T
MIRALPEIX M
PALACIOS JM
CASTRO A
MARTINEZ A
Citation: V. Segarra et al., PHOSPHODIESTERASE INHIBITORY PROPERTIES OF LOSARTAN - DESIGN AND SYNTHESIS OF NEW LEAD COMPOUNDS, Bioorganic & medicinal chemistry letters, 8(5), 1998, pp. 505-510
Authors:
DALPIAZ V
GIOVANNONI MP
CASTELLANA C
PALACIOS JM
BELETA J
DOMENECH T
SEGARRA V
Citation: V. Dalpiaz et al., HETEROCYCLIC-FUSED 3(2H)-PYRIDAZINONES AS POTENT AND SELECTIVE PDE-IVINHIBITORS - FURTHER STRUCTURE-ACTIVITY-RELATIONSHIPS AND MOLECULAR MODELING STUDIES, European journal of medicinal chemistry, 33(10), 1998, pp. 789-797
Authors:
CANETE A
JOVANI C
LOPEZ A
COSTA E
SEGARRA V
FERNANDEZ JM
VERDEGUER A
VELAZQUEZ J
CASTEL V
Citation: A. Canete et al., SURGICAL-TREATMENT FOR NEUROBLASTOMA - COMPLICATIONS DURING 15 YEARS EXPERIENCE, Journal of pediatric surgery, 33(10), 1998, pp. 1526-1530
Authors:
CRESPO MI
PAGES L
VEGA A
SEGARRA V
LOPEZ M
DOMENECH T
MIRALPEIX M
BELETA J
RYDER H
PALACIOS JM
Citation: Mi. Crespo et al., DESIGN, SYNTHESIS, AND BIOLOGICAL-ACTIVITIES OF NEW THIENO[3,2-D]PYRIMIDINES AS SELECTIVE TYPE-4 PHOSPHODIESTERASE INHIBITORS, Journal of medicinal chemistry, 41(21), 1998, pp. 4021-4035
Authors:
DALPIAZ V
GIOVANNONI MP
CASTELLANA C
PALACIOS JM
BELETA J
DOMENECH T
SEGARRA V
Citation: V. Dalpiaz et al., NOVEL HETEROCYCLIC-FUSED PYRIDAZINONES AS POTENT AND SELECTIVE PHOSPHODIESTERASE-IV INHIBITORS, Journal of medicinal chemistry, 40(10), 1997, pp. 1417-1421
Authors:
SEGARRA V
CARRERA F
FABREGAS JL
CLARAMUNT J
Citation: V. Segarra et al., DEGRADATION PROFILE AND IDENTIFICATION OF THE MAJOR DEGRADATION PRODUCTS OF DOBUPRIDE UNDER SEVERAL CONDITIONS BY GC MS AND HPLC-PARTICLE BEAM MS/, Journal of pharmaceutical and biomedical analysis, 13(8), 1995, pp. 987-993
Authors:
DIEZ A
VOLDOIRE A
LOPEZ I
RUBIRALTA M
SEGARRA V
PAGES L
PALACIOS JM
Citation: A. Diez et al., SYNTHETIC APPLICATIONS OF 2-ARYL-4-PIPERIDONES .10. SYNTHESIS OF 3-AMINOPIPENDINES, POTENTIAL SUBSTANCE-P ANTAGONISTS, Tetrahedron, 51(17), 1995, pp. 5143-5156
Citation: Jm. Palacios et al., 2ND MESSENGER SYSTEMS AS TARGETS FOR NEW THERAPEUTIC AGENTS - FOCUS ON SELECTIVE PHOSPHODIESTERASE INHIBITORS, Il Farmaco, 50(12), 1995, pp. 819-827